Addenbrooke's Cognitive Examination validation in Parkinson's disease
- Autores
- Reyes, M. A.; Perez Lloret, Santiago; Gerscovich, E. R.; Martin, M. E.; Leiguarda, R.; Merello, Marcelo Jorge
- Año de publicación
- 2009
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: There is a clear need for brief, sensitive and specific cognitive screening instruments in Parkinson's disease (PD). Objectives: To study Addenbrooke's Cognitive Examination (ACE) validity for cognitive assessment of PD patient's using the Mattis Dementia Rating Scale (MDRS) as reference method. A specific scale for cognitive evaluation in PD, in this instance the Scales for Outcomes of Parkinson's disease - Cognition (SCOPA-COG), as well as a general use scale the Mini-mental state examination (MMSE) were also studied for further correlation. Methods: Forty-four PD patients were studied, of these 27 were males (61%), with a mean (SD) age of 69.5 (11.8) years, mean (SD) disease duration of 7.6 (6.4) years (range 1-25), mean (SD) total Unified Parkinson's Disease Rating Scale (UPDRS) score 37 (24) points, UPDRS III 16.5 (11.3) points. MDRS, ACE and SCOPA-COG scales were administered in random order. All patients remained in on-state during the study. Results: Addenbrooke's Cognitive Examination correlated with SCOPA-COG (r = 0.93, P < 0.0001), and MDRS (r = 0.91 P < 0.0001) and also with MMSE (r = 0.84, P < 0.001). Area under the receiver-operating curve, taking MDRS as the reference test, was 0.97 [95% confidence interval (CI): 0.92-1.00] for ACE, 0.92 (95% CI: 0.83-1.00) for SCOPA-COG and 0.91 (95% CI: 0.83-1.00) for MMSE. Best cut-off value for ACE was 83 points [Sensitivity (Se) = 92%; Specificity (Sp) = 91%; Kappa concordance (K) = 0.79], 20 points for the SCOPA-COG (Se = 92%; Sp = 87%; K = 0.74) and 26 points for MMSE (Se = 61%; Sp = 100%; K = 0.69). Conclusion: Addenbrooke's Cognitive Examination appears to be a valid tool for dementia evaluation in PD, with a cut-off point which should probably be set at 83 points, displaying good correlation with both the scale specifically designed for cognitive deficits in PD namely SCOPA-COG, as well as with less specific tests such as MMSE.
Fil: Reyes, M. A.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Universidad Militar Nueva Granada; Colombia
Fil: Perez Lloret, Santiago. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Gerscovich, E. R.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina
Fil: Martin, M. E.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina
Fil: Leiguarda, R.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina
Fil: Merello, Marcelo Jorge. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
-
COGNITIVE EVALUATION
DEMENTIA
NEUROLOGY
PARKINSON 'S DISEASE
VALIDATION STUDY - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/118107
Ver los metadatos del registro completo
id |
CONICETDig_18b0cf275b77567c7abd81811e85eafb |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/118107 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Addenbrooke's Cognitive Examination validation in Parkinson's diseaseReyes, M. A.Perez Lloret, SantiagoGerscovich, E. R.Martin, M. E.Leiguarda, R.Merello, Marcelo JorgeCOGNITIVE EVALUATIONDEMENTIANEUROLOGYPARKINSON 'S DISEASEVALIDATION STUDYhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background: There is a clear need for brief, sensitive and specific cognitive screening instruments in Parkinson's disease (PD). Objectives: To study Addenbrooke's Cognitive Examination (ACE) validity for cognitive assessment of PD patient's using the Mattis Dementia Rating Scale (MDRS) as reference method. A specific scale for cognitive evaluation in PD, in this instance the Scales for Outcomes of Parkinson's disease - Cognition (SCOPA-COG), as well as a general use scale the Mini-mental state examination (MMSE) were also studied for further correlation. Methods: Forty-four PD patients were studied, of these 27 were males (61%), with a mean (SD) age of 69.5 (11.8) years, mean (SD) disease duration of 7.6 (6.4) years (range 1-25), mean (SD) total Unified Parkinson's Disease Rating Scale (UPDRS) score 37 (24) points, UPDRS III 16.5 (11.3) points. MDRS, ACE and SCOPA-COG scales were administered in random order. All patients remained in on-state during the study. Results: Addenbrooke's Cognitive Examination correlated with SCOPA-COG (r = 0.93, P < 0.0001), and MDRS (r = 0.91 P < 0.0001) and also with MMSE (r = 0.84, P < 0.001). Area under the receiver-operating curve, taking MDRS as the reference test, was 0.97 [95% confidence interval (CI): 0.92-1.00] for ACE, 0.92 (95% CI: 0.83-1.00) for SCOPA-COG and 0.91 (95% CI: 0.83-1.00) for MMSE. Best cut-off value for ACE was 83 points [Sensitivity (Se) = 92%; Specificity (Sp) = 91%; Kappa concordance (K) = 0.79], 20 points for the SCOPA-COG (Se = 92%; Sp = 87%; K = 0.74) and 26 points for MMSE (Se = 61%; Sp = 100%; K = 0.69). Conclusion: Addenbrooke's Cognitive Examination appears to be a valid tool for dementia evaluation in PD, with a cut-off point which should probably be set at 83 points, displaying good correlation with both the scale specifically designed for cognitive deficits in PD namely SCOPA-COG, as well as with less specific tests such as MMSE.Fil: Reyes, M. A.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Universidad Militar Nueva Granada; ColombiaFil: Perez Lloret, Santiago. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Gerscovich, E. R.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; ArgentinaFil: Martin, M. E.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; ArgentinaFil: Leiguarda, R.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; ArgentinaFil: Merello, Marcelo Jorge. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaWiley Blackwell Publishing, Inc2009-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/118107Reyes, M. A.; Perez Lloret, Santiago; Gerscovich, E. R.; Martin, M. E.; Leiguarda, R.; et al.; Addenbrooke's Cognitive Examination validation in Parkinson's disease; Wiley Blackwell Publishing, Inc; European Journal of Neurology; 16; 1; 1-2009; 142-1471351-5101CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1468-1331.2008.02384.xinfo:eu-repo/semantics/altIdentifier/doi/10.1111/j.1468-1331.2008.02384.xinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:40:27Zoai:ri.conicet.gov.ar:11336/118107instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:40:28.126CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Addenbrooke's Cognitive Examination validation in Parkinson's disease |
title |
Addenbrooke's Cognitive Examination validation in Parkinson's disease |
spellingShingle |
Addenbrooke's Cognitive Examination validation in Parkinson's disease Reyes, M. A. COGNITIVE EVALUATION DEMENTIA NEUROLOGY PARKINSON 'S DISEASE VALIDATION STUDY |
title_short |
Addenbrooke's Cognitive Examination validation in Parkinson's disease |
title_full |
Addenbrooke's Cognitive Examination validation in Parkinson's disease |
title_fullStr |
Addenbrooke's Cognitive Examination validation in Parkinson's disease |
title_full_unstemmed |
Addenbrooke's Cognitive Examination validation in Parkinson's disease |
title_sort |
Addenbrooke's Cognitive Examination validation in Parkinson's disease |
dc.creator.none.fl_str_mv |
Reyes, M. A. Perez Lloret, Santiago Gerscovich, E. R. Martin, M. E. Leiguarda, R. Merello, Marcelo Jorge |
author |
Reyes, M. A. |
author_facet |
Reyes, M. A. Perez Lloret, Santiago Gerscovich, E. R. Martin, M. E. Leiguarda, R. Merello, Marcelo Jorge |
author_role |
author |
author2 |
Perez Lloret, Santiago Gerscovich, E. R. Martin, M. E. Leiguarda, R. Merello, Marcelo Jorge |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
COGNITIVE EVALUATION DEMENTIA NEUROLOGY PARKINSON 'S DISEASE VALIDATION STUDY |
topic |
COGNITIVE EVALUATION DEMENTIA NEUROLOGY PARKINSON 'S DISEASE VALIDATION STUDY |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background: There is a clear need for brief, sensitive and specific cognitive screening instruments in Parkinson's disease (PD). Objectives: To study Addenbrooke's Cognitive Examination (ACE) validity for cognitive assessment of PD patient's using the Mattis Dementia Rating Scale (MDRS) as reference method. A specific scale for cognitive evaluation in PD, in this instance the Scales for Outcomes of Parkinson's disease - Cognition (SCOPA-COG), as well as a general use scale the Mini-mental state examination (MMSE) were also studied for further correlation. Methods: Forty-four PD patients were studied, of these 27 were males (61%), with a mean (SD) age of 69.5 (11.8) years, mean (SD) disease duration of 7.6 (6.4) years (range 1-25), mean (SD) total Unified Parkinson's Disease Rating Scale (UPDRS) score 37 (24) points, UPDRS III 16.5 (11.3) points. MDRS, ACE and SCOPA-COG scales were administered in random order. All patients remained in on-state during the study. Results: Addenbrooke's Cognitive Examination correlated with SCOPA-COG (r = 0.93, P < 0.0001), and MDRS (r = 0.91 P < 0.0001) and also with MMSE (r = 0.84, P < 0.001). Area under the receiver-operating curve, taking MDRS as the reference test, was 0.97 [95% confidence interval (CI): 0.92-1.00] for ACE, 0.92 (95% CI: 0.83-1.00) for SCOPA-COG and 0.91 (95% CI: 0.83-1.00) for MMSE. Best cut-off value for ACE was 83 points [Sensitivity (Se) = 92%; Specificity (Sp) = 91%; Kappa concordance (K) = 0.79], 20 points for the SCOPA-COG (Se = 92%; Sp = 87%; K = 0.74) and 26 points for MMSE (Se = 61%; Sp = 100%; K = 0.69). Conclusion: Addenbrooke's Cognitive Examination appears to be a valid tool for dementia evaluation in PD, with a cut-off point which should probably be set at 83 points, displaying good correlation with both the scale specifically designed for cognitive deficits in PD namely SCOPA-COG, as well as with less specific tests such as MMSE. Fil: Reyes, M. A.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Universidad Militar Nueva Granada; Colombia Fil: Perez Lloret, Santiago. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Gerscovich, E. R.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina Fil: Martin, M. E.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina Fil: Leiguarda, R.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina Fil: Merello, Marcelo Jorge. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
description |
Background: There is a clear need for brief, sensitive and specific cognitive screening instruments in Parkinson's disease (PD). Objectives: To study Addenbrooke's Cognitive Examination (ACE) validity for cognitive assessment of PD patient's using the Mattis Dementia Rating Scale (MDRS) as reference method. A specific scale for cognitive evaluation in PD, in this instance the Scales for Outcomes of Parkinson's disease - Cognition (SCOPA-COG), as well as a general use scale the Mini-mental state examination (MMSE) were also studied for further correlation. Methods: Forty-four PD patients were studied, of these 27 were males (61%), with a mean (SD) age of 69.5 (11.8) years, mean (SD) disease duration of 7.6 (6.4) years (range 1-25), mean (SD) total Unified Parkinson's Disease Rating Scale (UPDRS) score 37 (24) points, UPDRS III 16.5 (11.3) points. MDRS, ACE and SCOPA-COG scales were administered in random order. All patients remained in on-state during the study. Results: Addenbrooke's Cognitive Examination correlated with SCOPA-COG (r = 0.93, P < 0.0001), and MDRS (r = 0.91 P < 0.0001) and also with MMSE (r = 0.84, P < 0.001). Area under the receiver-operating curve, taking MDRS as the reference test, was 0.97 [95% confidence interval (CI): 0.92-1.00] for ACE, 0.92 (95% CI: 0.83-1.00) for SCOPA-COG and 0.91 (95% CI: 0.83-1.00) for MMSE. Best cut-off value for ACE was 83 points [Sensitivity (Se) = 92%; Specificity (Sp) = 91%; Kappa concordance (K) = 0.79], 20 points for the SCOPA-COG (Se = 92%; Sp = 87%; K = 0.74) and 26 points for MMSE (Se = 61%; Sp = 100%; K = 0.69). Conclusion: Addenbrooke's Cognitive Examination appears to be a valid tool for dementia evaluation in PD, with a cut-off point which should probably be set at 83 points, displaying good correlation with both the scale specifically designed for cognitive deficits in PD namely SCOPA-COG, as well as with less specific tests such as MMSE. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/118107 Reyes, M. A.; Perez Lloret, Santiago; Gerscovich, E. R.; Martin, M. E.; Leiguarda, R.; et al.; Addenbrooke's Cognitive Examination validation in Parkinson's disease; Wiley Blackwell Publishing, Inc; European Journal of Neurology; 16; 1; 1-2009; 142-147 1351-5101 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/118107 |
identifier_str_mv |
Reyes, M. A.; Perez Lloret, Santiago; Gerscovich, E. R.; Martin, M. E.; Leiguarda, R.; et al.; Addenbrooke's Cognitive Examination validation in Parkinson's disease; Wiley Blackwell Publishing, Inc; European Journal of Neurology; 16; 1; 1-2009; 142-147 1351-5101 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1468-1331.2008.02384.x info:eu-repo/semantics/altIdentifier/doi/10.1111/j.1468-1331.2008.02384.x |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614432937738240 |
score |
13.070432 |